Couverture de The Lancet Microbe in conversation with

The Lancet Microbe in conversation with

The Lancet Microbe in conversation with

De : The Lancet Group
Écouter gratuitement

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

Editors at The Lancet Microbe, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.

A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from using probiotics to reduce Staphylococcus aureus, to phage therapy and monitoring antimicrobial resistance using faecal metagenomes, and more.

© 2026 The Lancet Group Hygiène et vie saine Maladie et pathologies physiques Science
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Amber Barton on mass drug administration to eradicate yaws in Papua New Guinea

      Amber Barton on mass drug administration to eradicate yaws in Papua New Guinea
      Jan 6 2026

      Phoebe Ashley-Norman of The Lancet Microbe speaks to Amber Barton about the neglected tropical disease, yaws. Efforts to eradicate yaws were first made in the 1950s through a WHO and UNICEF campaign that reduced yaws prevalence by 90%, but it remained endemic in some regions.

      Global efforts involving the mass drug administration of azithromycin continue in pursuit of the WHO 2030 yaws eradication goal. In this podcast, Amber discusses how genomic epidemiology can be used to investigate the effectiveness of yaws eradication strategies, detect sublineages of yaws at higher resolution, and improve our understanding of macrolide resistance.

      Click here to read the full article: https://www.thelancet.com/journals/lanmic/article/piiS2666-5247(25)00157-0/fulltext

      Continue this conversation on social!
      Follow us today at...
      https://thelancet.bsky.social/
      https://instagram.com/thelancetgroup
      https://facebook.com/thelancetmedicaljournal
      https://linkedIn.com/company/the-lancet
      https://youtube.com/thelancettv
      Afficher plus Afficher moins
      21 min
    • Britt Koskella on bacteriophages as a signature of microbiome health

      Britt Koskella on bacteriophages as a signature of microbiome health
      Dec 22 2025

      Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Britt Koskella about bacteriophages and phageome, their role in modulating the bacteriome, their potential use as signatures of microbiome health and dysbiosis, and hence, indirectly, as markers of host health and disease status.

      From an ecological perspective, parasites (such as bacteriophages) are key drivers of the evolution of their hosts (bacteria), and so one might expect to find diverse and rich bacteriomes in the presence of a highly diverse and thriving microbiome: Britt has been exploring this possibility and discusses it in this episode.

      Click here to read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00124-7/fulltext

      Continue this conversation on social!
      Follow us today at...
      https://thelancet.bsky.social/
      https://instagram.com/thelancetgroup
      https://facebook.com/thelancetmedicaljournal
      https://linkedIn.com/company/the-lancet
      https://youtube.com/thelancettv
      Afficher plus Afficher moins
      27 min
    • Christian Malaka and Livia Patrono on the surveillance of mpox in the Central African Republic

      Christian Malaka and Livia Patrono on the surveillance of mpox in the Central African Republic
      Nov 3 2025

      Rebecca Barksby of The Lancet Microbe speaks to Dr Christian Malaka and Dr Livia Patrono on mpox in the Central African Republic and how researchers are using genomic surveillance to provide insights into the epidemiology of the virus.

      Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00101-6/fulltext

      Continue this conversation on social!
      Follow us today at...
      https://thelancet.bsky.social/
      https://instagram.com/thelancetgroup
      https://facebook.com/thelancetmedicaljournal
      https://linkedIn.com/company/the-lancet
      https://youtube.com/thelancettv
      Afficher plus Afficher moins
      33 min
    Aucun commentaire pour le moment